Guide to revision of national pandemic influenza preparedness plans: Lessons learned from the 2009 A(H1N1) pandemic
This guide is intended for use by those involved in pandemic preparedness planning, generic preparedness and implementation of IHR core capacities in European countries. The document describes good practice for pandemic preparedness planning based on lessons learned from the 2009 pandemic.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Assessment of human influenza pandemic scenarios in Europe
Napoli, C., Fabiani, M., Rizzo, C., Barral, M., Oxford, J., Cohen, J.M., Niddam, L., Goryński, P., Pistol, A., Lionis, C., Bri, S., Nicoll, A., Penttinen, P., Gauci, C., Bounekkar, A., Bonnevay, S., Beresniak, A.
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.
Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA): Influenza
This report which is part of the RAGIDA project (Risk Assessment Guidance for Infectious Diseases transmitted on Aircraft) provides viable options for decision-makers when faced with the choice of whether to contact trace air travellers and crew that were potentially exposed to infectious diseases during a flight.
- Avian influenza virus
- Infectious diseases on aircrafts
- Influenza A (H1N1)2009
- Influenza A(H5N1) virus
- Influenza A(H5N2) virus
- Influenza A(H5N8) virus
- Influenza A(H7N9) virus
- Influenza in humans, avian origin
- Influenza in humans, pandemic
- Influenza in humans, seasonal
- Influenza in humans, swine origin
- Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA)
- Travellers' health
School closures during the 2009 influenza pandemic: National and local experiences
Cauchemez, S., Van Kerkhove, M.D., Archer, B.N., Cetron, M., Cowling, B.J., Grove, P., Hunt, D., Kojouharova, M., Kon, P., Ungchusak, K., Oshitani, H., Pugliese, A., Rizzo, C., Saour, G., Sunagawa, T., Uzicanin, A., Wachtel, C., Weisfuse, I., Yu, H., Nicoll, A.
Weekly influenza surveillance overview, Nov 15, 2013 - week 45
During week 45/2013: All 27 reporting countries experienced low intensity influenza activity.
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
Surveillance of hospitalised severe cases of influenza A(H1N1)pdm09 and related fatalities in nine EU countries in 2010-2011.
Snacken, R., Quinten, C., Devaux, I., Plata, F., Broberg, E., Zucs, P., Amato-Gauci, A.